Yuval Kluger

Yuval Kluger

Auto-generated profile, based on publicly available information

Yuval Kluger

Yale University

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 February 2018 in BMC Medical Research Methodology
Verified
Journal Article
Open access
PDF file
JKJared L. Katzman
Jared L. Katzman
USUri Shaham
Uri Shaham
ACAlexander Cloninger
Alexander Cloninger
JBJonathan Bates
Jonathan Bates
TJTingting Jiang
Tingting Jiang
YKYuval Kluger
Yuval Kluger
Medical practitioners use survival models to explore and understand the relationships between patients’ covariates (e.g. clinical and genetic features) and the effectiveness of various treatment options. Standard survival models like the linear Cox proportional hazards model require extensive feature engineering or prior medical knowledge to model treatment interaction at an individual level. While nonlinear survival methods, such as neural networks and survival forests, can inherently model these high-level interaction terms, they have yet to be shown as effective treatment recommender systems. We introduce DeepSurv, a Cox proportional hazards deep neural network and state-of-the-art survival method for modeling interactions between a patient’s covariates and treatment effectiveness in order to provide personalized treatment recommendations. We perform a number of experiments training DeepSurv on simulated and real survival data. We demonstrate that DeepSurv performs as well as or better than other state-of-the-art survival models and validate that DeepSurv successfully models increasingly complex relationships between a patient’s covariates and their risk of failure. We then show how DeepSurv models the relationship between a patient’s features and effectiveness of different treatment options to show how DeepSurv can be used to provide individual treatment recommendations. Finally, we train DeepSurv on real clinical studies to demonstrate how it’s personalized treatment recommendations would increase the survival time of a set of patients. The predictive and modeling capabilities of DeepSurv will enable medical researchers to use deep neural networks as a tool in their exploration, understanding, and prediction of the effects of a patient’s characteristics on their risk of failure.

11 February 2019 in Nature Methods
Verified
Journal Article
Closed access
PDF file
GLGeorge Linderman
George Linderman
MRManas Rachh
Manas Rachh
JHJeremy G. Hoskins
Jeremy G. Hoskins
SSStefan Steinerberger
Stefan Steinerberger
YKYuval Kluger
Yuval Kluger

28 April 2022 in Nature
Verified
Journal Article
Open access
PDF file
ESEsen Sefik
Esen Sefik
RQRihao Qu
Rihao Qu
CJCaroline Furtado Junqueira
Caroline Furtado Junqueira
EKEleanna Kaffe
Eleanna Kaffe
HMHaris Mirza
Haris Mirza
RFRichard A. Flavell
Richard A. Flavell
Severe COVID-19 is characterized by persistent lung inflammation, inflammatory cytokine production, viral RNA and a sustained interferon (IFN) response, all of which are recapitulated and required for pathology in the SARS-CoV-2-infected MISTRG6-hACE2 humanized mouse model of COVID-19, which has a human immune system1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20. Blocking either viral replication with remdesivir21,22,23 or the downstream IFN-stimulated cascade with anti-IFNAR2 antibodies in vivo in the chronic stages of disease attenuates the overactive immune inflammatory response, especially inflammatory macrophages. Here we show that SARS-CoV-2 infection and replication in lung-resident human macrophages is a critical driver of disease. In response to infection mediated by CD16 and ACE2 receptors, human macrophages activate inflammasomes, release interleukin 1 (IL-1) and IL-18, and undergo pyroptosis, thereby contributing to the hyperinflammatory state of the lungs. Inflammasome activation and the accompanying inflammatory response are necessary for lung inflammation, as inhibition of the NLRP3 inflammasome pathway reverses chronic lung pathology. Notably, this blockade of inflammasome activation leads to the release of infectious virus by the infected macrophages. Thus, inflammasomes oppose host infection by SARS-CoV-2 through the production of inflammatory cytokines and suicide by pyroptosis to prevent a productive viral cycle.

15 March 2023 in Nature
Verified
Journal Article
Open access
PDF file
DZDi Zhang
Di Zhang
YDYanxiang Deng
Yanxiang Deng
PKPetra Kukanja
Petra Kukanja
EAEneritz Agirre
Eneritz Agirre
MBMarek Bartosovic
Marek Bartosovic
RFRong Fan
Rong Fan
Emerging spatial technologies, including spatial transcriptomics and spatial epigenomics, are becoming powerful tools for profiling of cellular states in the tissue context1–5. However, current methods capture only one layer of omics information at a time, precluding the possibility of examining the mechanistic relationship across the central dogma of molecular biology. Here, we present two technologies for spatially resolved, genome-wide, joint profiling of the epigenome and transcriptome by cosequencing chromatin accessibility and gene expression, or histone modifications (H3K27me3, H3K27ac or H3K4me3) and gene expression on the same tissue section at near-single-cell resolution. These were applied to embryonic and juvenile mouse brain, as well as adult human brain, to map how epigenetic mechanisms control transcriptional phenotype and cell dynamics in tissue. Although highly concordant tissue features were identified by either spatial epigenome or spatial transcriptome we also observed distinct patterns, suggesting their differential roles in defining cell states. Linking epigenome to transcriptome pixel by pixel allows the uncovering of new insights in spatial epigenetic priming, differentiation and gene regulation within the tissue architecture. These technologies are of great interest in life science and biomedical research.

11 January 2022 in Nature Communications
Verified
Journal Article
Open access
PDF file
GLGeorge Linderman
George Linderman
JZJun Zhao
Jun Zhao
MRManolis Roulis
Manolis Roulis
PBPiotr Bielecki
Piotr Bielecki
RFRichard A. Flavell
Richard A. Flavell
YKYuval Kluger
Yuval Kluger
A key challenge in analyzing single cell RNA-sequencing data is the large number of false zeros, where genes actually expressed in a given cell are incorrectly measured as unexpressed. We present a method based on low-rank matrix approximation which imputes these values while preserving biologically non-expressed genes (true biological zeros) at zero expression levels. We provide theoretical justification for this denoising approach and demonstrate its advantages relative to other methods on simulated and biological datasets.

1 April 2020 in Nature
Verified
Journal Article
Closed access
PDF file
MRManolis Roulis
Manolis Roulis
AKAimilios Kaklamanos
Aimilios Kaklamanos
MSMarina Schernthanner
Marina Schernthanner
PBPiotr Bielecki
Piotr Bielecki
JZJun Zhao
Jun Zhao
RFRichard A. Flavell
Richard A. Flavell